ID
31176
Beschrijving
Study ID: 104505 Clinical Study ID: BEX104505 Study Title: Phase II Study of Iodine 131 Anti B1 Antibody for 1st or 2nd Relapsed Indolent B-Cell Lymphomas or B-Cell Lymphomas That Have Transformed to a More Aggressive Histology Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00950755 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: tositumomab Trade Name: Bexxar Study Indication: Lymphoma, Non-Hodgkin
Trefwoorden
Versies (1)
- 25-07-18 25-07-18 -
Houder van rechten
see clinicaltrials.gov
Geüploaded op
25 juli 2018
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Iodine 131 B1 Antibody for B-Cell Lymphomas NCT00950755
Notification of Patient Death
- StudyEvent: ODM
Beschrijving
Patient Death
Alias
- UMLS CUI-1
- C0011065
Beschrijving
Date of death
Datatype
date
Alias
- UMLS CUI [1]
- C1148348
Beschrijving
Cause of death
Datatype
text
Alias
- UMLS CUI [1]
- C0007465
Beschrijving
Complications of treatment
Datatype
text
Alias
- UMLS CUI [1,1]
- C0087111
- UMLS CUI [1,2]
- C0009566
Beschrijving
Study drug relation to death
Datatype
text
Alias
- UMLS CUI [1,1]
- C0011065
- UMLS CUI [1,2]
- C0304229
Beschrijving
Patient death; Source of Information
Datatype
text
Alias
- UMLS CUI [1,1]
- C0011065
- UMLS CUI [1,2]
- C1955348
- UMLS CUI [1,3]
- C0449416
Similar models
Notification of Patient Death
- StudyEvent: ODM
C0600091 (UMLS CUI [1,2])
C0009566 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,2])
C1955348 (UMLS CUI [1,2])
C0449416 (UMLS CUI [1,3])
Geen commentaren